MetMaxStruct: a Tversky-similarity-based strategy for analysing the (sub)structural similarities of drugs and endogenous metabolites
Background. Previous studies compared the molecular similarity of marketed drugs and endogenous human metabolites (endogenites), using a series of fingerprint-type encodings, variously ranked and clustered using the Tanimoto (Jaccard) similarity coefficient (TS). Because this gives equal weight to a...
Saved in:
Main Authors: | Steve O'Hagan (Author), Douglas Bruce Kell (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites
by: Steve eO'Hagan, et al.
Published: (2015) -
Consensus rank orderings of molecular fingerprints illustrate the most genuine similarities between marketed drugs and small endogenous human metabolites, but highlight exogenous natural products as the most important 'natural' drug transporter substrates
by: Steve O'Hagan, et al.
Published: (2017) -
Can emollients of similar composition be assumed to be therapeutically equivalent: a comparison of skin occlusivity and emulsion microstructure
by: Antonijević MD, et al.
Published: (2018) -
Predictive Potential of C<sub>max</sub> Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ<sub>2</sub> Similarity Factor Method
by: Sara Carolina Henriques, et al.
Published: (2023) -
The similarity of inherited diseases (I): clinical similarity within the phenotypic series
by: Alessio Gamba, et al.
Published: (2021)